Nigeria approves revised biotechnology policy
Analysis based on 6 articles · First reported Aug 20, 2026 · Last updated Aug 21, 2026
The approval signals Nigeria's commitment to advancing biotechnology, potentially attracting investment and fostering growth in the sector. It may positively impact related industries such as agriculture and healthcare, though the direct market impact is likely modest in the short term.
The Federal Executive Council (FEC) of Nigeria, chaired by President Bola Tinubu, approved the revised National Biotechnology Policy 2026 at its meeting on Wednesday. The policy updates Nigeria's 2001 biotechnology policy after 25 years of scientific and technological advances. It provides a framework for biotechnology research, development, application, and commercialization across agriculture, healthcare, industrial production, and environmental sustainability, and addresses emerging technologies such as precision agriculture, climate-smart technologies, advanced manufacturing, gene editing, and genomics. The approval also includes the Nigeria Biotechnology Partnership, formalizing Nigeria's participation in the Global Biotechnology Partnership, which is expected to strengthen access to international collaboration and investment. The Nigeria — National Biotechnology Research and Development Agency (NBRDA) welcomed the approval, with Director-General Mustapha Abdullahi stating it provides policy direction to promote innovation, technology transfer, and commercialization. NBRDA will collaborate with government institutions, research organizations, universities, and industry to implement the policy.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard